Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-004863-41Phase 3Completed
Phase 3, randomised trial in pulmonary arterial hypertension (PAH) comparing Simvastatin with Placebo (2 arms). Primary endpoint: Change in pulmonary artery pressure at 6 months. Started Jul 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-004863-41.